← Open Payments lookup

YOLA SARA: Open Payments

NPI 1649842923 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,081 in 140 payments from 16 companies in 2025. Trend: 2023 $1,351 · 2024 $2,383 · 2025 $4,081

Food & beverage: $4,081
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP21$857
ABBVIE INC.34$839
Novo Nordisk Inc18$482
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)12$453
GlaxoSmithKline, LLC.13$346
Lilly USA, LLC11$339
Otsuka America Pharmaceutical, Inc.11$280
Xeris Pharmaceuticals, Inc.5$208
Boehringer Ingelheim Pharmaceuticals, Inc.5$86
SANOFI-AVENTIS U.S. LLC3$59

Products named: VRAYLAR, CAPLYTA, AIRSUPRA, REXULTI, FARXIGA, Wegovy, TRELEGY ELLIPTA, FASENRA.

Industry payments across PA — which companies pay providers there.